ライフサイエンスコーパス: ng

1 d were 0.05 ng/mL for aflatoxin B(1) and 1.0 ng/mL for fumonisin B(1), with dynamic ranges extending

2 1) and a linear dynamic range of 6.3 - 100.0 ng . mL(-1) within a 5 min incubation with 1-naphthyl ph

3 , 0.5-0.99 ng/mL, 1.0-1.99 ng/mL, and >= 2.0 ng/mL).

4 (OH)D level at the end of the trial was 31.0 ng per milliliter in the vitamin D group and 10.7 ng per

5 in concentrations were lower in 12 g/d (46.0 ng/mL; 95% CI: 34.8, 60.9 ng/mL) than in 4 g/d (51.6 ng/

6 sh tissue samples ranged from <LOD to 797.00 ng/g of WW, where perfluorooctanesulfonate (PFOS) was th

7 oids in exposure concentrations of 10-10,000 ng/L.

8 Her serum ferritin was higher than 21,000 ng/mL and transferrin saturation reached 102%.

9 ncentrations were between 65 000 and 830 000 ng g(-1) wet weight, possibly the highest burden recorde

10 6 PFAS with concentrations as high as 97 000 ng/L (PFOS) along with longer-chain, more hydrophobic PF

11 under gelatin admixed conditions, was 0.005 ng/uL.

12 0.17 ng/uL, 0.039 ng/uL, 0.43 ng/uL, 0.0076 ng/uL for aldosterone, corticosterone, cortisol, and bet

13 ile of a normal reference population (>=0.01 ng/mL) between January 1, 2003, and December 31, 2012.

14 00 ng mL(-1) and limit of detection of 0.022 ng mL(-1) within 30 min toward OTA.

15 on limits were 0.39, 0.060, 0.021, and 0.025 ng mL(-1) for Pb(II), Cu(II), Cd(II), and Zn(II) cations

16 RP (cut-off 6.5 mg/L) and PCT (cut-off 0.025 ng/mL) were 52.3% (36.7-67.5%, 95%-CI) and 37.0% (23.2-5

17 2, 2020, with troponin-I (normal value <0.03 ng/ml) measured within 24 h of admission were included (

18 a 25-fold decrease in the LOD for sEH (0.03 ng/mL).

19 LOQ, linearity and matrix effect were 0.035 ng mL(-1), 0.1 ng mL(-1), 0.1-300 ng mL(-1), and 9.6% re

20 etected in aqua as low as; 0.17 ng/uL, 0.039 ng/uL, 0.43 ng/uL, 0.0076 ng/uL for aldosterone, cortico

21 (4)(+) are 3.52 ng m(-3) (5.05 ppt) and 1.04 ng m(-3), respectively.

22 The detection limits achieved were 0.05 ng/mL for aflatoxin B(1) and 1.0 ng/mL for fumonisin B(1

23 chieved a limit of detection as low as 0.056 ng/mL with high specificity, and also showed excellent a

24 levels were 8.72 +/- 2.93 and 7.85 +/- 3.07 ng/mL for MPA and mTORi group respectively, P = 0.277).

25 /ml in asymptomatic malaria, 843 (655-1,084) ng/ml in uncomplicated malaria and 1,369 (1,244-1,506) n

26 hile greater amounts (e.g., troponin I >0.09 ng/dl; n = 530; 19.4%) were significantly associated wit

27 rdial injury (e.g., troponin I >0.03 to 0.09 ng/ml; n = 455; 16.6%) were significantly associated wit

28 and matrix effect were 0.035 ng mL(-1), 0.1 ng mL(-1), 0.1-300 ng mL(-1), and 9.6% respectively, wit

29 hs-cTnI levels by 0.5 ng/L (CI, -0.9 to -0.1 ng/L) and NT-proBNP levels by 0.3 pg/mL (CI, -0.5 to -0.

30 ng/mL at week 12; of these, one had MPA <0.1 ng/mL at week 10.

31 omen (11.9%; 95% CI, 4.0-25.6%) had MPA <0.1 ng/mL at week 12; of these, one had MPA <0.1 ng/mL at we

32 seline to 3 mo) in serum vitamin D3 was -0.1 ng/mL in the placebo group and 6.8 ng/mL in the 2000 IU/

33 nsitive data, with linear responses from 0.1 ng/mL to 100 mug/mL and operating well in the presence o

34 able first serum PSA value after RARP (>=0.1 ng/mL) at least 6 wk after surgery, in the absence of an

35 ary outcome measure, MPA concentration (<0.1 ng/mL) at week 12, was assessed using exact 95% Clopper-

36 entic SARS-CoV-2 with an IC(50) value of 3.1 ng/mL.

37 For octisalate, concentrations were 5.1 ng/mL (CV, 81.6%) for aerosol spray, 5.8 ng/mL (CV, 77.4

38 in (AFP) at diagnosis and pre-LDLT were 78.1 ng/mL (3-58 200) and 55 ng/mL (2-7320), respectively.

39 5,734 +/- 350 peptide-spectrum matches for 1 ng of a HeLa digest, using a 1 h gradient at the flow ra

40 In patients with PSA levels >= 1 ng/mL the DR and PPV were 90% and 91%, respectively, res

41 In patients with PSA levels < 1 ng/mL, the DR and PPV were 69% and 85%, respectively, re

42 enable the sensitive enrichment of cTnI (<1 ng/mL) with high specificity and reproducibility, while

43 t PSA levels of 0.2 to <0.5 ng/mL, 0.5 to <1 ng/mL, 1 to <2 ng/mL, and >=2 ng/mL, respectively.

44 f CRP in serum, and a large working range (1 ng/mL - 100 mug/mL) of clinical relevance has been also

45 al recurrence and a PSA level of less than 1 ng/mL.

46 and the detection limit can be reduced to 1 ng/mL.

47 8; 95% CI: - 0.03, 1.19, respectively, for 1-ng/mL increases] and ponderal index SDS (beta = 0.36; 95

48 ith appropriate limits of detection (0.05-10 ng/g) and limits of quantitation (0.15-30 ng/g) for the

49 much lower than the stablished MRL (0.10-10 ng/g), while granting satisfactory linearity (R(2) > 0.9

50 nge of <limit of detection [<LOD] to 1670.10 ng/g of wet weight [WW]).

51 vel established by Regulation EU/10/2011 (10 ng g(-1)).

52 ifferentiating the concentrations (blank, 10 ng ml(-1), 100 ng ml(-1), and 1 mug ml(-1)) of IgG antib

53 lin G, detection limits of 1.5 ng/mL and >10 ng/mL were achieved in buffer and serum, respectively.

54 ost associated with the increase of AFP >=10 ng/ml according to multivariate analysis were the etiolo

55 atients with an alpha-fetoprotein (AFP) >=10 ng/mL and having used sirolimus for >=3 months, benefite

56 ot a positive fingerprint of PS when just 10 ng of the polymer was present within the dissolved organ

57 te-specific antigen (PSA) level less than 10 ng/mL.

58 the concentrations (blank, 10 ng ml(-1), 100 ng ml(-1), and 1 mug ml(-1)) of IgG antibody (CR3022) to

59 nd Co(II) were 0.05-80 ng mL(-1) and 0.2-100 ng mL(-1), respectively.

60 samples with CIP at a concentration of 9,100 ng L(-1).

61 l total PA concentrations reached almost 100 ng/L in late spring and summer.

62 t samples, with medians of approximately 100 ng/g dust or greater.

63 Cirrhosis, >1 nodule, and AFP >100 ng/mL were identified as preoperative predictors of NTR.

64 level <=11 g/dL; serum ferritin level <=100 ng/mL) and intolerance or unresponsiveness to 1 month or

65 m 1.50 to 500 pg mL(-1) and from 0.50 to 100 ng mL(-1).

66 ory concentrations (IC50s) in the 10- to 100-ng/mL range.

67 th allergen extracts of each nut (0.001-1000 ng/mL protein).

68 aptasensor showed a linear range of 0.1-1000 ng mL(-1) and limit of detection of 0.022 ng mL(-1) with

69 rbCAPG (Control, vehicle, CAPG 10, 100, 1000 ng/mL: n = 3 biological replicates per treatment per spe

70 on curve was linear over the range of 5-1000 ng g(-1) with a correlation coefficient higher than 0.99

71 amazepine (33-910 ng/L), diclofenac (78-1000 ng/L), carbendazim (21-900 ng/L), diazinon (2.1-53 ng/L)

72 er sample with concentrations exceeding 1000 ng/L at 13 sample sites within an 8 km radius of the pla

73 s in media increased in the presence of 1000 ng mL(-1) FNP while mycelial quantities of the metabolit

74 pg/m(3) in indoor air, and 49, 670, and 110 ng/g in wristbands, respectively.

75 /L), diazinon (2.1-53 ng/L), diuron (22-1100 ng/L), mecoprop (98-5300 ng/L), metolachlor (6-230 ng/L)

76 Vitamin D deficiency (<12 ng/mL) is associated with reduced ambulation after hip f

77 were characterized according to 25(OH)D <12 ng/mL, 12 to <20 ng/mL, 20 to <30 ng/mL, or >=30 ng/mL.

78 CI) increased with severity, being 7 (4-12) ng/ml in asymptomatic malaria, 843 (655-1,084) ng/ml in

79 tween 7 and 10, 150 and 250, or 800 and 1200 ng/mL.

80 <5865 ng L(-1)), three BPF isomers (8.2-1286 ng L(-1)) and BPAP (1.6 ng L(-1)), while bottles leached

81 ed higher in the LPV/r arm: 0.45 versus 0.13 ng/mL (P = .002).

82 d specificity (71%) for PE diagnosis at 1394 ng/mL d-dimer units.

83 f detection of 0.26 IU/mL (624 pg/mL) and 14 ng/mL for IgE and IgG antibodies, respectively.

84 (PFOS) concentrations were as high as 72-140 ng/L at one location.

85 e, 28 km north of the plant, had PFOA at 143 ng/L and HFPO-DA at 42 ng/L.

86 A very low limit of detection of about 0.15 ng/mL was obtained during the detection of CRP in serum,

87 t Air 3-month Quality Standard for lead (150 ng m(-3)).

88 d a linear behavior from 40 ng mL(-1) to 150 ng mL(-1) of PARK7/DJ-1 with a limit of detection of 7.5

89 tions reached (~ 950, ~ 1200, ~ 1400, ~ 1500 ng cm(-2) for CH(3), OH, COOH and NH(2) SAMs) were consi

90 n the concentration ranges from 0.01 to 1500 ng mL(-1) and the limits of detection were in a range fr

91 nces and UV filters in both biota (136.9-159 ng g(-1)) and the dissolved phase (3322.2-265.7 ng L(-1)

92 oids can be detected in aqua as low as; 0.17 ng/uL, 0.039 ng/uL, 0.43 ng/uL, 0.0076 ng/uL for aldoste

93 ifferent grilled meat samples were 2.75-6.17 ng g(-1).

94 icantly higher than Weck-Cel sponges (16,173 ng, p = 0.0336).

95 The mean d-dimer level was 1774 ng/mL and 6432 ng/mL d-dimer units in CT pulmonary angio

96 rs were found at concentrations of up to 178 ng g(-1) (d.w.).

97 imits of detection were in a range from 0.18 ng L(-1) to 74 ng mL(-1).

98 windows of susceptibility, DomA (0.09 - 0.18 ng) was delivered to zebrafish through caudal vein micro

99 of the cysts, CEA level was higher than 192 ng/mL in 39.4% of patients, and only 35% of cytologic sa

100 TnI levels by 0.5 ng/L (95% CI, -0.9 to -0.2 ng/L) and NT-proBNP levels by 0.3 pg/mL (CI, -0.5 to -0.

101 pecific antigen (PSA) levels of at least 0.2 ng/mL and negative conventional imaging results were enr

102 s were 31.8%, 44.9%, and 71.4% for PSA < 0.2 ng/mL, 0.2 <= PSA < 0.5, and 0.5 <= PSA < 1, respectivel

103 .5%) patients with a PSA level less than 0.2 ng/mL.

104 /ng/L/cm(2) for chlorpyrifos (CPF); and 10.2 ng/L with sensitivity 0.58 mA/ng/L/cm(2) for methyl para

105 is generally determined to be ca. 0.5 to 6.2 ng/mL (3.9 to 40.5 nM) by high-performance liquid chroma

106 trations of Sigma(10)OPAHs were 10.0 +/- 9.2 ng/m(3) in winter and 3.5 +/- 1.6 ng/m(3) in summer.

107 ion 519/2014 showed that samples exceeding 2 ng/mL were properly scored as uncompliant.

108 /mL, 0.5 to <1 ng/mL, 1 to <2 ng/mL, and >=2 ng/mL, respectively.

109 (half-maximal inhibitory concentration of <2 ng/ml).

110 0.2 to <0.5 ng/mL, 0.5 to <1 ng/mL, 1 to <2 ng/mL, and >=2 ng/mL, respectively.

111 d and quiescent CD4 T cells (cultured with 2 ng/ml interleukin-7).

112 [CI], 1.03-1.30) and alpha-fetoprotein < 20 ng/mL (OR, 1.90; 95% CI, 1.12-3.21).

113 ed according to 25(OH)D <12 ng/mL, 12 to <20 ng/mL, 20 to <30 ng/mL, or >=30 ng/mL.

114 2bN0M0, prostate-specific antigen [PSA] <=20 ng/mL, and Grade Group 1-2) prostate cancer and 619 men

115 baseline serum 25(OH)D level of less than 20 ng per milliliter.

116 sensitized mice treated intranasally with 20 ng/kg of IRL201104 show a significant increase in the ex

117 > 0.998) in a wide linear range of 0.1-2000 ng/g, repeatability with RSDs < 10%, reproducibility RSD

118 and the detection limit was calculated as 22 ng/mL (n = 6) using the 3 Sb/m formula.

119 6 ng L(-1)), while bottles leached BPA (<222 ng L(-1)) and BPF, BPE, BPB and BPZ (1.1-4.6 ng L(-1)).

120 arbaryl was detected in apple (2.75 +/- 0.23 ng kg(-1)), carbofuran in tomato (11.34 +/- 0.61 ng kg(-

121 8.92), 59.19 (95% CI: 51.84-66.54) and 35.23 ng/kg (95% CI: 31.53-38.92), considering 4, 55 and 18 TL

122 mecoprop (98-5300 ng/L), metolachlor (6-230 ng/L), and terbutryn (29-810 ng/L).

123 Before the WWTP replacement, in vitro ER (24 ng 17beta-estradiol equivalents/L)-, GR (60 ng dexametha

124 Combined with PCT &0.25 ng/ml, LFA could reduce unnecessary antibacterial use by

125 At a rhMMP-9 volume of 20 mul (>= 25 ng/ml), ophthalmologists and densitometry identified alm

126 Weck-Cel: 8588 ng, p < 0.0001; Merocel: 2509 ng, p = 0.0389).

127 d of samples using the OriCol method (75,253 ng) was comparable to that using Merocel (71,672 ng; p =

128 ombomodulin concentrations greater than 3.26 ng/mL were associated with lower rates of hospital disch

129 da), obtaining concentrations of 549 and 267 ng L(-1).

130 mg twice daily, the median exposure was 2780 ng/(mL.h) for patients with CrCl 25 to 30 mL/min.

131 observed across all habitats (range: 11-280 ng/g).

132 is allows for homogeneous dissolution of 1.3 ng of fluorescently labeled dAbs in 416 nL of the sample

133 d beers (>21%) in the range from 0.6 to 12.3 ng mL(-1).

134 o group (mean between-group difference, 20.3 ng per milliliter; 95% CI, 19.9 to 20.6).

135 n early life had 2.8-ng/mL (95% CI: 0.3, 5.3 ng/mL) higher leptin and tended to have lower fasting gl

136 (absolute difference: 6.9; 95% CI: 4.5, 9.3 ng/mL).

137 Baseline hs-cTnT (limit of detection [LoD] 3 ng/l) and CAC measurements were analyzed across particip

138 x 10(3), 6.0-4.5 x 10(3), and 15-3.0 x 10(3) ng kg(-1) and limits of detection of 1.37 +/- 0.10, 4.7

139 10 ng/g) and limits of quantitation (0.15-30 ng/g) for the analytes tested.

140 s of Tacrolimus on month 3 (9.48 versus 7.30 ng/mL, P = 0.023).

141 prenatal VD sufficiency (25(OH)D level >= 30 ng/mL) status during pregnancy in women with and without

142 L, 12 to <20 ng/mL, 20 to <30 ng/mL, or >=30 ng/mL.

143 Serum 25(OH)VD levels < 30 ng/mL were defined as VD insufficiency/deficiency.

144 5(OH)D <12 ng/mL, 12 to <20 ng/mL, 20 to <30 ng/mL, or >=30 ng/mL.

145 roxyvitamin D concentrations of less than 30 ng/mL at four large HIV care and treatment centres in Da

146 were 0.035 ng mL(-1), 0.1 ng mL(-1), 0.1-300 ng mL(-1), and 9.6% respectively, with high preconcentra

147 concentrations (measured average: 38 or 312 ng/L) or a solvent control for 15 months using a mesocos

148 ive to placebo (n = 46; CTx = 0.123 vs 0.324 ng/mL; P < .001); at 144 weeks a 25% difference between

149 mg twice daily were 5512 ng/(mL.h) and 3406 ng/(mL.h) for patients with CrCl 25 to 30 mL/min or >30

150 to laboratory-reared beetles (2,452-145,348 ng per beetle); cholesterol and sitosterol were the domi

151 Urinary CD163 <370 ng/mmol or >370 ng/mmol perfectly agreed (kappa=1.0) with a histologic a

152 Urinary CD163 <370 ng/mmol or >370 ng/mmol perfectly agreed (kappa=1.0) wit

153 esion molecule-1 (WA: 153.9 ng/mL; CB: 159.4 ng/mL; P = 0.028), and increased serum uric acid (WA: 34

154 s after treatment discontinuation were 288.4 ng per deciliter in the relugolix group and 58.6 ng per

155 han in 4 g/d (51.6 ng/mL; 95% CI: 39.0, 68.4 ng/mL; P = 0.038).

156 An increase (P = 0.016) from baseline (73.4 ng/mL) to 24 hours after hypoglycemia (91.7 ng/mL) was s

157 l curves presented a linear behavior from 40 ng mL(-1) to 150 ng mL(-1) of PARK7/DJ-1 with a limit of

158 ian PSA level of 0.96 ng/mL (range, 0.01-400 ng/mL).

159 of the biosensor was found between 5 and 400 ng/mL, and the detection limit was calculated as 22 ng/m

160 lant, had PFOA at 143 ng/L and HFPO-DA at 42 ng/L.

161 qua as low as; 0.17 ng/uL, 0.039 ng/uL, 0.43 ng/uL, 0.0076 ng/uL for aldosterone, corticosterone, cor

162 present at high concentrations (maximum 448 ng/g in soil, 3.4 mg/L in groundwater).

163 ficantly improved limit of detection of 0.46 ng and linear dynamic range of 3 orders of magnitude in

164 f 0.97 ng/mL (interquartile range: 0.41-2.46 ng/mL) were included.

165 TEP (summer 13-160 and winter 18-46, ng/L) and TCPP (summer 242-4282 and winter 215-854, ng/L

166 ection limit of the sensor is as low as 0.47 ng/L, and it can be successfully applied to the detectio

167 sor provides PfLDH quantitation down to 2.47 ng mL(-1) in spiked samples and for 0.006-1.5% parasitem

168 th a lowest detection limit of 0.38 and 0.48 ng/mL, respectively.

169 ime-weighted average concentration: 250-4800 ng/L), carbamazepine (33-910 ng/L), diclofenac (78-1000

170 vegetable diet reduced hs-cTnI levels by 0.5 ng/L (95% CI, -0.9 to -0.2 ng/L) and NT-proBNP levels by

171 the DASH diet reduced hs-cTnI levels by 0.5 ng/L (CI, -0.9 to -0.1 ng/L) and NT-proBNP levels by 0.3

172 atients with a PSA level between 0.2 and 0.5 ng/mL and in 10 of 26 (38.5%) patients with a PSA level

173 nd how quickly systemic exposure exceeds 0.5 ng/mL as recommended by the US Food and Drug Administrat

174 tate specific antigen (PSA) values below 0.5 ng/mL compared with the already high detection rate of (

175 and 95% (76/80) at PSA levels of 0.2 to <0.5 ng/mL, 0.5 to <1 ng/mL, 1 to <2 ng/mL, and >=2 ng/mL, re

176 %, respectively, for patients with PSA < 0.5 ng/mL, 0.5-0.99 ng/mL, 1.0-1.99 ng/mL, and >= 2.0 ng/mL)

177 l 6 active ingredients were greater than 0.5 ng/mL, and this threshold was surpassed on day 1 after a

178 f patients with a PSA level of less than 0.5 ng/mL, which could substantially impact clinical managem

179 d 80% had limits of quantification below 0.5 ng/mL.

180 r, even at low PSA levels no higher than 0.5 ng/mL.

181 se immunoglobulin G, detection limits of 1.5 ng/mL and >10 ng/mL were achieved in buffer and serum, r

182 level within the upper normal range (8-11.5 ng/mL) was more frequently associated with severe anaphy

183 PEs had median concentrations of 4.5 and 2.5 ng g(-1), respectively.

184 The hs-cTnI cutoff of 2.5 ng/L provided an NPV of 70% (95% CI, 64% to 75%) and a s

185 cluding hs-cTnI concentrations less than 2.5 ng/L, do not generally allow users to safely exclude ind

186 ivity and serum aldosterone were 6.8 vs. 5.5 ng/mL/h (p = 0.002) and 654 vs. 473 pg/mL (p = 0.01), re

187 nd 62.5 ng/mL (PSAG-1) and from 0.64 to 62.5 ng/mL (anti-PSA), with a reproducibility of 5.4 %.

188 m with a dynamic range between 0.26 and 62.5 ng/mL (PSAG-1) and from 0.64 to 62.5 ng/mL (anti-PSA), w

189 PARK7/DJ-1 with a limit of detection of 7.5 ng mL(-1).

190 at baseline to 20.8 +/- 8.1 and 20.8 +/- 8.5 ng/mL at 24 and 48 weeks, respectively (p < 0.001).

191 environmentally relevant concentrations of 5 ng L(-1) with TEM-EDX and sp-ICP-MS measurements.

192 ccurate, requires only 2.5 hours, and uses 5 ng of antigen per test.

193 -risk (clinical stage cT2cN0M0, PSA of 20-50 ng/mL, or Grade Group 3-5) prostate cancer diagnosed in

194 th dynamic ranges extending up to 5.0 and 50 ng/mL, respectively.

195 4 nM 17beta-estradiol (E) for seven days, 50 ng/ml E.coli flagellin (F) for 12 h, or 4 nM 17beta-estr

196 Screening cutoff values of 8-OHdG >50 ng/mg of creatinine or urine creatinine >1.5 mg minimize

197 At a rhMMP-9 volume of 10 mul (>= 50 ng/ml), all positive results were identified by densitom

198 osterone suppression to castrate levels (<50 ng per deciliter) through 48 weeks.

199 ) for 12 h, or 4 nM 17beta-estradiol plus 50 ng/ml flagellin (E + F(12 h)).

200 ng 5 orders of magnitude from 0.28 to 13 500 ng/L, with 38 compounds detected in >50% of samples.

201 d sample was varied in a range from 1 to 500 ng, and the method demonstrated 10-fold higher sensitivi

202 d is linear over a dynamic range of 1 to 500 ng/mg.

203 ncomplicated malaria and 1,369 (1,244-1,506) ng/ml in severe malaria.

204 redicting intravascular coagulation was 0.51 ng/L with 63% sensitivity and 61% specificity with area

205 3 s/n) values of NH(3) and NH(4)(+) are 3.52 ng m(-3) (5.05 ppt) and 1.04 ng m(-3), respectively.

206 macrophage activation (D-dimer median, 5284 ng/mL).

207 carbendazim (21-900 ng/L), diazinon (2.1-53 ng/L), diuron (22-1100 ng/L), mecoprop (98-5300 ng/L), m

208 L), diuron (22-1100 ng/L), mecoprop (98-5300 ng/L), metolachlor (6-230 ng/L), and terbutryn (29-810 n

209 d pre-LDLT were 78.1 ng/mL (3-58 200) and 55 ng/mL (2-7320), respectively.

210 urve for apixaban 5 mg twice daily were 5512 ng/(mL.h) and 3406 ng/(mL.h) for patients with CrCl 25 t

211 ols (0.59/0.31-0.88/ng/mL vs. 0.31/0.31-0.58/ng/mL; p = 0.005) after adjustment for gender, age, BMI

212 Cans leached BPA (<5865 ng L(-1)), three BPF isomers (8.2-1286 ng L(-1)) and BPA

213 g infected olive samples, with a LOD of 0.59 ng and a LOQ of 1.8 ng, allowing its application to orch

214 The biosensor showed detection limit of 1.6 ng . mL(-1) and a linear dynamic range of 6.3 - 100.0 ng

215 PF isomers (8.2-1286 ng L(-1)) and BPAP (1.6 ng L(-1)), while bottles leached BPA (<222 ng L(-1)) and

216 .0 +/- 9.2 ng/m(3) in winter and 3.5 +/- 1.6 ng/m(3) in summer.

217 ng L(-1)) and BPF, BPE, BPB and BPZ (1.1-4.6 ng L(-1)).

218 mL (CV, 77.4%) for nonaerosol spray, and 4.6 ng/mL (CV, 97.6%) for pump spray.

219 5% CI: 34.8, 60.9 ng/mL) than in 4 g/d (51.6 ng/mL; 95% CI: 39.0, 68.4 ng/mL; P = 0.038).

220 er deciliter in the relugolix group and 58.6 ng per deciliter in the leuprolide group.

221 ng/mL (CV, 78.1%) for aerosol spray, and 6.6 ng/mL (CV, 103.9%) for nonaerosol spray.

222 s were 7.8 ng/mL (CV, 87.1%) for lotion, 6.6 ng/mL (CV, 78.1%) for aerosol spray, and 6.6 ng/mL (CV,

223 TnT (high sensitivity cardiac troponin-T) <6 ng/L and NT-proBNP (N-terminal pro-B-type natriuretic pe

224 high-risk patients with a mean tacrolimus <6 ng/ml versus >8 ng/ml had increased risk of DR/DQ DSA at

225 tion, and reaches a maximum value of ~10(-6) ng of iron per cell.

226 was performed at a median PSA value of 0.60 ng/mL (interquartile range, 0.3-2.4) after a median of 6

227 None of the patients with suPAR <4.60 ng/ml required dialysis during their hospitalization.

228 ng 17beta-estradiol equivalents/L)-, GR (60 ng dexamethasone equivalents/L)-, and PPARgamma-mediated

229 A single cutoff concentration >60 ng/l identified patients at high risk with a positive pr

230 ce was based on a tamoxifen serum level < 60 ng/mL, assessed 1 year after prescription.

231 D-dimer greater than 2,600 ng/mL predicted venous thromboembolism with an area unde

232 g(-1)), carbofuran in tomato (11.34 +/- 0.61 ng kg(-1)), and methomyl in watermelon (34.7 +/- 1.7 ng

233 The median suPAR level was 5.61 ng/ml.

234 25th-75th percentiles) were 2.22 (1.06-4.61) ng/L in 2001-2002 and 1.18 (<limit of detection-2.92) ng

235 ls increased (1.06 +/- 1.03 to 1.66 +/- 1.64 ng/mL; P < 0.001) following periodontal treatment.

236 e mean d-dimer level was 1774 ng/mL and 6432 ng/mL d-dimer units in CT pulmonary angiography-negative

237 is LFA in buffer and measured an LOD of 0.65 ng/mL (95% CI of 0.53 to 0.77 ng/mL) ng/mL with recombin

238 Mass spectrometry analysis detected 2.67 ng/mL of Ro5-3335 within the vitreous cavity after treat

239 etection frequencies of 100% in air (E(6)670 ng m(-3) geomean) and floor dust (E(6)630 mug g(-1)), ne

240 was comparable to that using Merocel (71,672 ng; p = 0.6942) but significantly higher than Weck-Cel s

241 e no significant differences in leptin (-0.7 ng/mL; -2.1, 0.8 ng/mL) or fasting glucose (0.2 mmol/L;

242 )), and methomyl in watermelon (34.7 +/- 1.7 ng kg(-1)).

243 r milliliter in the vitamin D group and 10.7 ng per milliliter in the placebo group (mean between-gro

244 25(OH)VD levels decreased from 26.3 +/- 10.7 ng/mL at baseline to 20.8 +/- 8.1 and 20.8 +/- 8.5 ng/mL

245 g(-1)) and the dissolved phase (3322.2-265.7 ng L(-1)).

246 1.37 +/- 0.10, 4.7 +/- 1.2, and 10.1 +/- 5.7 ng kg(-1) were obtained, respectively.

247 limits of the method ranged from 0.3 to 6.7 ng L(-1).

248 NO(2) were 45.3 ug/m(3), 9.7 ng/m(3), 707.7 ng/m(3), and 91.5 ug/m(3), respectively.

249 , BaP, NAP, and NO(2) were 45.3 ug/m(3), 9.7 ng/m(3), 707.7 ng/m(3), and 91.5 ug/m(3), respectively.

250 ng/mL) to 24 hours after hypoglycemia (91.7 ng/mL) was seen for urinary isoprostanes.

251 ion levels with adequate detection limits (7 ng/L, S/N = 3).

252 FAS-impacted water that meets the current 70 ng/L of PFOA and PFOS U.S. Environmental Protection Agen

253 th the greatest mean concentration of 463.73 ng/g.

254 icant (p < 0.05) increase of PAH4 (0.19-7.73 ng/g) with an increase in temperatures (110-190 degrees

255 mL/ng and a limit of detection (LOD) of 0.74 ng/mL.

256 ion were in a range from 0.18 ng L(-1) to 74 ng mL(-1).

257 an LOD of 0.65 ng/mL (95% CI of 0.53 to 0.77 ng/mL) ng/mL with recombinant antigen using an optical r

258 ns which were the highest in northern (88.77 ng/kg).

259 differences in leptin (-0.7 ng/mL; -2.1, 0.8 ng/mL) or fasting glucose (0.2 mmol/L; -0.5, 0.9 mmol/L)

260 ples, with a LOD of 0.59 ng and a LOQ of 1.8 ng, allowing its application to orchard management.

261 antigen with limits of detection of 1.4-2.8 ng mL(-1).

262 5.1 ng/mL (CV, 81.6%) for aerosol spray, 5.8 ng/mL (CV, 77.4%) for nonaerosol spray, and 4.6 ng/mL (C

263 was -0.1 ng/mL in the placebo group and 6.8 ng/mL in the 2000 IU/d group (absolute difference: 6.9;

264 For octocrylene, the concentrations were 7.8 ng/mL (CV, 87.1%) for lotion, 6.6 ng/mL (CV, 78.1%) for

265 limit of detection (LoD) was found to be 8.8 ng/L with sensitivity 0.41 mA/ng/L/cm(2) for chlorpyrifo

266 ts with a mean tacrolimus <6 ng/ml versus >8 ng/ml had increased risk of DR/DQ DSA at 1 year (HR 2.34

267 to improved nutrition in early life had 2.8-ng/mL (95% CI: 0.3, 5.3 ng/mL) higher leptin and tended

268 nearities for Ni(II) and Co(II) were 0.05-80 ng mL(-1) and 0.2-100 ng mL(-1), respectively.

269 olachlor (6-230 ng/L), and terbutryn (29-810 ng/L).

270 nd TCPP (summer 242-4282 and winter 215-854, ng/L) were the main OPEs.

271 than secretions from sponges (Weck-Cel: 8588 ng, p < 0.0001; Merocel: 2509 ng, p = 0.0389).

272 ith OSA compared to controls (0.59/0.31-0.88/ng/mL vs. 0.31/0.31-0.58/ng/mL; p = 0.005) after adjustm

273 HET mice receiving CAF (plasma CAF 893 ng/ml) have significantly shorter times to respiratory a

274 cellular cell adhesion molecule-1 (WA: 153.9 ng/mL; CB: 159.4 ng/mL; P = 0.028), and increased serum

275 er in 12 g/d (46.0 ng/mL; 95% CI: 34.8, 60.9 ng/mL) than in 4 g/d (51.6 ng/mL; 95% CI: 39.0, 68.4 ng/

276 clofenac (78-1000 ng/L), carbendazim (21-900 ng/L), diazinon (2.1-53 ng/L), diuron (22-1100 ng/L), me

277 ation: 250-4800 ng/L), carbamazepine (33-910 ng/L), diclofenac (78-1000 ng/L), carbendazim (21-900 ng

278 001-2002 and 1.18 (<limit of detection-2.92) ng/L in 2011-2012.

279 261 patients had a median PSA level of 0.96 ng/mL (range, 0.01-400 ng/mL).

280 532 patients with a median PSA level of 0.97 ng/mL (interquartile range: 0.41-2.46 ng/mL) were includ

281 The mean of AFM1 levels was obtained 55.97 ng/kg (95% CI: 50.09-61.84).

282 rs were found at concentrations of up to 982 ng g(-1) (d.w.) and phthalate monoesters were found at c

283 d in OriCol-collected rectal secretions (986 ng) was lower than secretions from sponges (Weck-Cel: 85

284 for patients with PSA < 0.5 ng/mL, 0.5-0.99 ng/mL, 1.0-1.99 ng/mL, and >= 2.0 ng/mL).

285 th PSA < 0.5 ng/mL, 0.5-0.99 ng/mL, 1.0-1.99 ng/mL, and >= 2.0 ng/mL).

286 r prasugrel active metabolite concentration (ng/mL; 62.3+/-82.6 versus 17.1+/-43.5; P=0.016).

287 r release into the environment, resulting in ng L(-1) traces in natural water bodies.

288 gher prostate-specific antigen (PSA) levels (ng/mL): 50% (PSA < 0.5), 69% (0.5 <= PSA < 1), 100% (1 <

289 cific Antigen in clinically relevant levels (ng/ml), paving the way towards applications in large mul

290 s at sufficiently low quantification limits (ng/L).

291 od linear mass response (R(2) = 0.9983), low ng/m(3) limits of detection (LoD), and a fast response t

292 Individual PAs were in the low ng/L range, but rain-induced maximal total PA concentrat

293 ound to be 8.8 ng/L with sensitivity 0.41 mA/ng/L/cm(2) for chlorpyrifos (CPF); and 10.2 ng/L with se

294 CPF); and 10.2 ng/L with sensitivity 0.58 mA/ng/L/cm(2) for methyl parathion (MP).

295 of 0.65 ng/mL (95% CI of 0.53 to 0.77 ng/mL) ng/mL with recombinant antigen using an optical reader w

296 rated a moderate sensitivity of 0.0164 OD.mL/ng and a limit of detection (LOD) of 0.74 ng/mL.

297 16-fold increase in sensitivity (0.262 OD.mL/ng) and a 25-fold decrease in the LOD for sEH (0.03 ng/m

298 Detection limits as low as tens of ng m(-3) with linearity up to hundreds of mug m(-3) at 0

299 t a mean concentration of 62.8 +/- 38.2 (SE) ng/m(3) or equivalent to published concentrations in dus

300 be rapid (15 soil samples/h) and sensitive (ng/g level detection limits).

301 dian (interquartile range) values for sTXB2 (ng/mL) compared with the once-daily arm: 4 (2.1-6.7; n =

302 ations were identified and quantified in the ng/mL range using hydrophilic interaction liquid chromat